{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:03:25Z","timestamp":1792724605374,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,15]],"date-time":"2027-06-15T00:00:00Z","timestamp":1813017600000},"content-version":"am","delay-in-days":410,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI25\/00647"],"award-info":[{"award-number":["PI25\/00647"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1 R01 AR081382-01A1"],"award-info":[{"award-number":["1 R01 AR081382-01A1"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031734","name":"Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031734","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["PI25\/00647"],"award-info":[{"award-number":["PI25\/00647"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.berh.2026.102117","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:49:13Z","timestamp":1769806153000},"page":"102117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-1539","authenticated-orcid":false,"given":"Luis G.","family":"Alcala-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Malagelada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-8940","authenticated-orcid":false,"given":"Zsuzsanna H.","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41584-023-00929-1","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr.24488","article-title":"Relationship between gastrointestinal transit, medsger gastrointestinal severity, and university of California-Los Angeles Scleroderma clinical trial consortium gastrointestinal tract 2.0 symptoms in patients with systemic sclerosis","volume":"74","author":"McMahan","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.semarthrit.2019.05.005","article-title":"Evaluation of risk factors for pseudo-obstruction in systemic sclerosis","volume":"49","author":"Dein","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2026.102117_bib4","article-title":"Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosis","volume":"7","author":"Cheah","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-089725","article-title":"Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study","volume":"14","author":"Alcala-Gonzalez","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib6","article-title":"Chronic intestinal pseudo-obstruction in adults: a practical guide to identify patient subgroups that are suitable for more specific treatments","volume":"36","author":"Basilisco","year":"2024","journal-title":"Neuro Gastroenterol Motil"},{"issue":"2","key":"10.1016\/j.berh.2026.102117_bib7","first-page":"63","article-title":"Current insights on chronic intestinal dysmotility: pseudo-obstruction and enteric dysmotility","volume":"116","author":"Alcal\u00e1 Gonz\u00e1lez","year":"2024","journal-title":"Rev Esp Enferm Dig"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib8","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3899\/jrheum.131547","article-title":"Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction","volume":"41","author":"Mecoli","year":"2014","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib9","article-title":"Functional and anatomical gastric regions and their relations to motility control","volume":"35","author":"Di Natale","year":"2023","journal-title":"Neuro Gastroenterol Motil"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","article-title":"The enteric nervous system and neurogastroenterology","volume":"9","author":"Furness","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib11","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.ard.2025.06.2119","article-title":"Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility","volume":"84","author":"McMahan","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.42667","article-title":"Anti-gephyrin antibodies: a novel specificity in patients with systemic sclerosis and lower bowel dysfunction","volume":"76","author":"McMahan","year":"2024","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.berh.2026.102117_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/acr.25118","article-title":"Antivinculin antibodies in systemic sclerosis: associations with slow gastric transit and extraintestinal clinical phenotype","author":"Herr\u00e1n","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2026.102117_bib14","article-title":"Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation","volume":"10","author":"Di Ciommo","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib15","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1093\/rheumatology\/keaf197","article-title":"Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis","volume":"64","author":"Ayla","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib16","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gut.2005.086074","article-title":"A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)","volume":"55","author":"Roberts","year":"2006","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-020-05325-8","article-title":"Intestinal hypomotility in systemic sclerosis: a histological study into the sequence of events","volume":"40","author":"den Braber-Ymker","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41575-018-0030-9","article-title":"Clinical measurement of gastrointestinal motility and function: who, when and which test?","volume":"15","author":"Fox","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10620-023-08151-5","article-title":"Diffuse gastrointestinal motor compromise in patients with scleroderma: utility of minimally invasive techniques","volume":"69","author":"von M\u00fchlenbrock","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00042737-200511000-00009","article-title":"Small intestinal manometry in patients with systemic sclerosis","volume":"17","author":"Sj\u00f6lund","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/rheumatology\/kel203","article-title":"Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up","volume":"46","author":"Marie","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib22","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1529-0131(199810)41:10<1874::AID-ART21>3.0.CO;2-T","article-title":"Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study","volume":"41","author":"Marie","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2026.102117_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5056\/jnm22168","article-title":"Small intestinal bacterial overgrowth complicating gastrointestinal manifestations of systemic sclerosis: a systematic review and meta-analysis","volume":"29","author":"Shah","year":"2023","journal-title":"J Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10067-019-04810-z","article-title":"Prevalence of malnutrition in systemic sclerosis patients assessed by different diagnostic tools","volume":"39","author":"Wojteczek","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2026.102117_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/acr.25569","article-title":"Avoidant or restrictive food intake disorder symptoms in adults with systemic sclerosis: a nationwide study in Spain","author":"Alcala-Gonzalez","year":"2025","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.berh.2026.102117_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/BOR.0000000000001048","article-title":"Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research","volume":"36","author":"Haussmann","year":"2024","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101687","article-title":"The microbiome and systemic sclerosis: a review of current evidence","volume":"35","author":"Tan","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib28","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1093\/rheumatology\/keab262","article-title":"A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis","volume":"60","author":"Teaw","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.berh.2026.102117_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/BOR.0000000000001110","article-title":"Gastrointestinal manifestations of systemic sclerosis: current approaches and emerging therapies","volume":"37","author":"Alcala-Gonzalez","year":"2025","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/acr.23479","article-title":"Determining the risk factors and clinical features associated with severe gastrointestinal dysmotility in systemic sclerosis","volume":"70","author":"McMahan","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2026.102117_bib32","article-title":"Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis","author":"Perin","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.berh.2026.102117_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/1744666X.2024.2320205","article-title":"Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach","volume":"20","author":"Kaniecki","year":"2024","journal-title":"Expet Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.berh.2026.102117_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/gut.21.4.293","article-title":"Small intestinal structure and passive permeability in systemic sclerosis","volume":"21","author":"Cobden","year":"1980","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/kes390","article-title":"Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort","volume":"52","author":"Forbess","year":"2013","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/j.gastro.2020.08.061","article-title":"AGA clinical practice update on the evaluation and management of seronegative enteropathies: expert review","volume":"160","author":"Leonard","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrgastro.2018.7","article-title":"Expert consensus document: advances in the diagnosis and classification of gastric and intestinal motility disorders","volume":"15","author":"Keller","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib38","article-title":"Comparison between small bowel manometric patterns and full-thickness biopsy histopathology in severe intestinal dysmotility","volume":"30","author":"Malagelada","year":"2018","journal-title":"Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc"},{"issue":"8","key":"10.1016\/j.berh.2026.102117_bib39","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/gut.2008.148296","article-title":"Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility","volume":"58","author":"Lindberg","year":"2009","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib40","article-title":"A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry","volume":"30","author":"Ang","year":"2018","journal-title":"Neuro Gastroenterol Motil"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib41","article-title":"Clinical significance of small bowel manometry patterns suggestive of intestinal obstruction","volume":"35","author":"Alcal\u00e1-Gonz\u00e1lez","year":"2023","journal-title":"Neuro Gastroenterol Motil"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib42","article-title":"Propagation patterns of jejunal motor activity measured by high-resolution water-perfused manometry","volume":"33","author":"Alcala-Gonzalez","year":"2021","journal-title":"Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib43","article-title":"High-resolution versus conventional manometry for the diagnosis of small bowel motor dysfunction","volume":"36","author":"Alcala-Gonzalez","year":"2024","journal-title":"Neuro Gastroenterol Motil"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib44","article-title":"Distinctive gastrointestinal motor dysfunction in patients with MNGIE","volume":"35","author":"Alcal\u00e1-Gonz\u00e1lez","year":"2023","journal-title":"Neuro Gastroenterol Motil"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2026.102117_bib45","article-title":"Op0067 categorization of small intestinal involvement in systemic sclerosis using high-resolution jejunal manometry","volume":"83","author":"Alcala-Gonzalez","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib46","article-title":"Evaluation of gastrointestinal motility with MRI: advances, challenges and opportunities","volume":"30","author":"de Jonge","year":"2018","journal-title":"Neuro Gastroenterol Motil"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.gtc.2020.04.006","article-title":"Enhancing scintigraphy for evaluation of gastric, small bowel, and colonic motility","volume":"49","author":"Maurer","year":"2020","journal-title":"Gastroenterol Clin N Am"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib48","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1007\/s10067-025-07676-6","article-title":"Prevalence, clinical characteristics, and hospital course of systemic sclerosis-associated pseudo-obstruction","volume":"44","author":"Ross","year":"2025","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3899\/jrheum.110225","article-title":"Minimally important differences of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument","volume":"38","author":"Khanna","year":"2011","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib50","first-page":"449","article-title":"Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study","volume":"3","author":"Stanghellini","year":"2005","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"4","key":"10.1016\/j.berh.2026.102117_bib51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/rheumatology\/key350","article-title":"Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality","volume":"58","author":"Richard","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib52","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib53","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/acr.23763","article-title":"Anti-RNPC-3 (U11\/U12) antibodies in systemic sclerosis in patients with moderate-to-severe gastrointestinal dysmotility","volume":"71","author":"McMahan","year":"2019","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib54","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00415-021-10577-8","article-title":"Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review","volume":"269","author":"Rossi","year":"2022","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.berh.2026.102117_bib55","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200369","article-title":"Novel approaches to treatment of immune-mediated chronic intestinal pseudo-obstruction","volume":"12","author":"Vilaseca","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.berh.2026.102117_bib56","article-title":"Pneumatosis cystoides intestinalis in patients with systemic sclerosis: a case report and review of 39 Japanese cases","volume":"2016","author":"Kaneko","year":"2016","journal-title":"Case Rep Gastrointest Med"},{"issue":"2","key":"10.1016\/j.berh.2026.102117_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/jpm14020167","article-title":"The challenge of pneumatosis intestinalis: a contemporary systematic review","volume":"14","author":"Perrone","year":"2024","journal-title":"J Personalized Med"},{"key":"10.1016\/j.berh.2026.102117_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaf064","article-title":"The role of prokinetics in managing gastrointestinal involvement in systemic sclerosis: a systematic literature review","author":"Ezquerra-Dur\u00e1n","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib59","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.52.11.1555","article-title":"Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans","volume":"52","author":"Foxx-Orenstein","year":"2003","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib60","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.36.5.743","article-title":"Differential regional effects of octreotide on human gastrointestinal motor function","volume":"36","author":"von der Ohe","year":"1995","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.berh.2026.102117_bib61","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/ans.18478","article-title":"Pyridostigmine in chronic intestinal pseudo-obstruction - a systematic review","volume":"93","author":"Wilkie","year":"2023","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semarthrit.2017.12.007","article-title":"Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis","volume":"48","author":"Ahuja","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2036.2011.04907.x","article-title":"Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study","volume":"35","author":"Emmanuel","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.berh.2026.102117_bib64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-017-1340-y","article-title":"Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study","volume":"19","author":"Vigone","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib76","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/gutjnl-2020-321631","article-title":"The management of adult patients with severe chronic small intestinal dysmotility","volume":"69","author":"Nightingale","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.berh.2026.102117_bib77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/17474124.2023.2193887","article-title":"Pharmacological and nutritional therapy of children and adults with chronic intestinal pseudo-obstruction","volume":"17","author":"Di Nardo","year":"2023","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102117_bib68","first-page":"540","article-title":"The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine","volume":"12","author":"O'Dea","year":"2010","journal-title":"Colorectal Dis Off J Assoc Coloproctology G B Irel"},{"issue":"21","key":"10.1016\/j.berh.2026.102117_bib78","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","article-title":"Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma","volume":"325","author":"Soudah","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.berh.2026.102117_bib79","first-page":"119","article-title":"Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients","volume":"13","author":"Nikou","year":"2007","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.berh.2026.102117_bib67","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2036.2004.01900.x","article-title":"Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response","volume":"19","author":"Emmanuel","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib80","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/nmo.12669","article-title":"Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders","volume":"27","author":"Parthasarathy","year":"2015","journal-title":"Neuro Gastroenterol Motil"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib81","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.berh.2026.102117_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2397198319863953","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"5","author":"Morrisroe","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib65","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.3390\/microorganisms9122549","article-title":"Chronic intestinal pseudo-obstruction: is there a connection with gut microbiota?","volume":"9","author":"Radocchia","year":"2021","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.berh.2026.102117_bib66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ueg2.12116","article-title":"The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth","volume":"9","author":"Richard","year":"2021","journal-title":"United Eur Gastroenterol J"},{"issue":"10","key":"10.1016\/j.berh.2026.102117_bib69","first-page":"e680","article-title":"Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases","volume":"25","author":"Sabbagh","year":"2013","journal-title":"Neuro Gastroenterol Motil"},{"issue":"5","key":"10.1016\/j.berh.2026.102117_bib70","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/gut.41.5.675","article-title":"Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults","volume":"41","author":"Mann","year":"1997","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.berh.2026.102117_bib71","article-title":"Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO)","volume":"29","author":"Ohkubo","year":"2017","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.berh.2026.102117_bib72","first-page":"309","article-title":"Micronutrient deficiencies in systemic sclerosis: a scoping review","volume":"14","author":"Nguyen","year":"2022","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"11","key":"10.1016\/j.berh.2026.102117_bib73","doi-asserted-by":"crossref","first-page":"G1052","DOI":"10.1152\/ajpgi.00034.2016","article-title":"Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG","volume":"310","author":"Kumar","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.berh.2026.102117_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead093","article-title":"Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration","author":"Matsuda","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.berh.2026.102117_bib75","article-title":"Efficacy assessment of intravenous immunoglobulin for gastrointestinal involvement in systemic sclerosis using UCLA SCTC GIT: case-based review","author":"Neto","year":"2024","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:20:30Z","timestamp":1785907230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1521694226000021"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102117","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102117"}}